VENTYX BIOSCIENCES INC's ticker is and the CUSIP is 92332V107. A total of 144 filers reported holding VENTYX BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $301,370,582 | +7.4% | 8,677,529 | +1.5% | 0.03% | +8.3% |
| Q2 2023 | $280,545,977 | -44.9% | 8,553,231 | -43.8% | 0.02% | +4.3% |
| Q1 2023 | $509,490,848 | +817.0% | 15,208,682 | +797.5% | 0.02% | +283.3% |
| Q4 2022 | $55,562,229 | -15.0% | 1,694,487 | -10.6% | 0.01% | -14.3% |
| Q3 2022 | $65,397,000 | +239.3% | 1,895,812 | +20.3% | 0.01% | +250.0% |
| Q2 2022 | $19,274,000 | +73.8% | 1,575,942 | +92.9% | 0.00% | +100.0% |
| Q1 2022 | $11,087,000 | -31.4% | 817,039 | +0.4% | 0.00% | 0.0% |
| Q4 2021 | $16,160,000 | – | 813,672 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 2,298,833 | $77,010,906 | 42.68% |
| Qiming U.S. Ventures Management, LLC | 746,370 | $25,003,395 | 30.26% |
| TCG Crossover Management, LLC | 815,724 | $27,326,754 | 5.33% |
| ACUTA CAPITAL PARTNERS, LLC | 208,500 | $6,984,750 | 5.15% |
| Affinity Asset Advisors, LLC | 260,008 | $8,710,268 | 2.88% |
| Avidity Partners Management LP | 1,917,800 | $64,246,300 | 2.13% |
| Integral Health Asset Management, LLC | 290,000 | $9,715,000 | 1.96% |
| Tri Locum Partners LP | 152,842 | $5,120,207 | 1.56% |
| Vivo Capital, LLC | 602,075 | $20,169,513 | 1.40% |
| Boxer Capital, LLC | 850,000 | $28,475 | 1.40% |